Vitamin D in Follicular Fluid Correlates With the Euploid Status of Blastocysts in a Vitamin D Deficient Population.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2020
Historique:
received: 23 09 2020
accepted: 03 12 2020
entrez: 15 2 2021
pubmed: 16 2 2021
medline: 27 5 2021
Statut: epublish

Résumé

The widespread distribution of the Vitamin D (VitD) receptor in reproductive tissues suggests an important role for VitD in human reproduction. The assessment of patient´s VitD is based on the 25-hydroxyvitamin D (25(OH)D) metabolite measurement. However, most of the circulating 25(OH)D is bound to either VitD-binding protein (VDBP) (88%) or albumin (12%) and less than 1% circulates free. To determine a possible correlation between VitD levels in serum (S) and follicular fluid (FF) and blastocyst ploidy status in patients undergoing infertility treatment. A prospective observational study was performed including couples planned for preimplantation genetic testing for aneuploidies (PGT-A) from ART Fertility Clinics. Patients were classified according to their 25(OH)D-Serum levels: VitD deficient group <20 ng/ml and insufficient/replete ≥20 ng/ml defined as VitD non-deficient group. Serum samples and 226 FF from individual follicles were collected for 25(OH)D, bioavailable 25(OH)D, free 25(OH)D, and % free 25(OH)D measurement. 25(OH)D-Serum in VitD deficient and non-deficient were 13.2±4.0 ng/ml vs 32.3±9.2 ng/ml; p<0.001. FF from 40 and 74 biopsied blastocysts was analysed of which 52.5 and 60.8% were euploid (p = 0.428), respectively. In VitD deficient patients, mean 25(OH)D-FF, bioavailable 25(OH)D-FF, and free 25(OH)D-FF were higher in euploid vs aneuploid blastocysts (18.3±6.3 ng/ml vs 13.9±4.8 ng/ml; p = 0.040; 1.5±0.5 ng/ml vs 1.1±0.4 ng/ml; p = 0.015; 0.005±0.002 ng/ml vs 0.003±0.001 ng/ml; p = 0.023, respectively), whilst no differences were found in VitD non-deficient patients (37.9±12.3 ng/ml vs 40.6±13.7 ng/ml; p = 0.380; 3.1±1.1 ng/ml vs 3.3±1.2 ng/ml; p = 0.323; 0.01±0.003 ng/ml vs 0.01±0.004 ng/ml; p = 0.319, respectively). VitD non-deficient patients have a significantly higher probability of obtaining a euploid blastocyst compared to VitD deficient patients (OR:33.36, p = 0.002).

Identifiants

pubmed: 33584542
doi: 10.3389/fendo.2020.609524
pmc: PMC7874043
doi:

Substances chimiques

Hydroxycholecalciferols 0
Vitamin D 1406-16-2

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

609524

Informations de copyright

Copyright © 2021 Arnanz, De Munck, El Khatib, Bayram, Abdala, Melado, Lawrenz, Coughlan, Pacheco, Garcia-Velasco and Fatemi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Hum Reprod Update. 2014 Jan-Feb;20(1):124-40
pubmed: 24077980
Am Fam Physician. 2018 Feb 15;97(4):226-227
pubmed: 29671531
Int J Mol Sci. 2016 Apr 06;17(4):372
pubmed: 27058533
Am J Obstet Gynecol. 2013 Feb;208(2):137.e1-13
pubmed: 23131462
J Reprod Fertil. 1991 Jan;91(1):59-64
pubmed: 1995862
Endocr Pract. 2017 May;23(5):605-613
pubmed: 28095044
Ann Agric Environ Med. 2016 Sep 27;23(4):671-676
pubmed: 28030942
Fertil Steril. 2014 Dec;102(6):1608-12
pubmed: 25256926
Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):132-7
pubmed: 21835540
Fertil Steril. 2014 Feb;101(2):447-52
pubmed: 24210230
Eur J Endocrinol. 2012 May;166(5):765-78
pubmed: 22275473
Hum Reprod. 2014 Sep;29(9):2032-40
pubmed: 24951484
Br J Nutr. 2009 Feb;101(4):487-91
pubmed: 18631414
J Assist Reprod Genet. 2019 Apr;36(4):661-665
pubmed: 30685837
Hum Reprod. 2018 Jan 1;33(1):65-80
pubmed: 29149263
Ann Nutr Metab. 2012;61(3):199-206
pubmed: 23183289
Curr Opin Obstet Gynecol. 1999 Jun;11(3):307-11
pubmed: 10369209
J Assist Reprod Genet. 2018 Feb;35(2):331-337
pubmed: 29063502
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Osteoporos Int. 1998;8 Suppl 2:S13-9
pubmed: 10197177
Fertil Steril. 2010 Sep;94(4):1314-1319
pubmed: 19589516
Int J Reprod Biomed. 2019 Nov 07;17(10):685-708
pubmed: 31807718
N Engl J Med. 2013 Nov 21;369(21):1991-2000
pubmed: 24256378
Reprod Biomed Online. 2015 Dec;31(6):760-9
pubmed: 26520420
Nutrients. 2018 Apr 13;10(4):
pubmed: 29652819
J Clin Endocrinol Metab. 2016 May;101(5):2226-34
pubmed: 27007693
Reprod Biomed Online. 2017 Aug;35(2):139-144
pubmed: 28625761
Fertil Steril. 2012 Jul;98(1):228-34
pubmed: 22494925
Reprod Biol Endocrinol. 2010 Jul 28;8:91
pubmed: 20667111
Reprod Biol Endocrinol. 2009 May 04;7:40
pubmed: 19413899
Hum Reprod. 2012 Nov;27(11):3321-7
pubmed: 22914766
Am J Obstet Gynecol. 2015 Mar;212(3):315.e1-6
pubmed: 25265402
Endocr Rev. 1989 Aug;10(3):232-74
pubmed: 2673754
Front Endocrinol (Lausanne). 2019 May 28;10:317
pubmed: 31191450
Reprod Biol Endocrinol. 2018 Feb 09;16(1):13
pubmed: 29426322
J Clin Invest. 1986 Sep;78(3):748-52
pubmed: 3745436
J Steroid Biochem Mol Biol. 2019 Jun;190:29-36
pubmed: 30904637
Bone. 2002 May;30(5):771-7
pubmed: 11996918
J Clin Endocrinol Metab. 2014 Nov;99(11):E2372-6
pubmed: 25121462
Fertil Steril. 2018 Sep;110(4):761-766.e1
pubmed: 30196974
Endocrinology. 2000 Apr;141(4):1317-24
pubmed: 10746634
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:132-7
pubmed: 24095930
BMC Pregnancy Childbirth. 2019 Nov 1;19(1):395
pubmed: 31675919
Neuro Endocrinol Lett. 2013;34(8):756-62
pubmed: 24522025
Fertil Steril. 2014 Aug;102(2):460-468.e3
pubmed: 24933120
Nutrients. 2019 May 10;11(5):
pubmed: 31083424
J Clin Endocrinol Metab. 2012 Jul;97(7):2450-5
pubmed: 22508713
Hum Reprod. 2018 Sep 1;33(9):1602-1618
pubmed: 30052961
Arch Gynecol Obstet. 2014 Jan;289(1):201-6
pubmed: 23880888
J Med Genet. 2014 Aug;51(8):553-62
pubmed: 25031024
Am J Clin Nutr. 2016 Sep;104(3):729-35
pubmed: 27465382
J Assist Reprod Genet. 2018 Jul;35(7):1265-1276
pubmed: 29774457
Hum Reprod. 2017 Jan;32(1):208-214
pubmed: 27927849

Auteurs

Ana Arnanz (A)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Neelke De Munck (N)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Ibrahim El Khatib (I)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Aşina Bayram (A)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Andrea Abdala (A)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Laura Melado (L)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Barbara Lawrenz (B)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.
Obstetrical Department, Women's University Hospital Tuebingen, Tuebingen, Germany.

Carol Coughlan (C)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Alberto Pacheco (A)

IVIRMA, Madrid, Spain.

Juan A Garcia-Velasco (JA)

IVIRMA, Madrid, Spain.
Department of Reproductive Endocrinology and Infertility, Rey Juan Carlos University, Madrid, Spain.

Human M Fatemi (HM)

ART Fertility Clinic, Abu Dhabi/Dubai, United Arab Emirates.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH